The Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). It was a treatise on how the PBMs are now wound, like poison ivy, around the trunk and boughs of the 300-foot healthcare tree. It coalesced intelligence about the PBM industry. It didn’t address ways to deal with the strangulating vine. … Continue reading The FTC Interim Report on PBMs: Prepare to Be Frustrated